Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Lab Accreditation Renewed

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warnex said on Monday that its Medical Laboratories division's accreditation has been renewed by the US healthcare accreditation organization COLA.

COLA initially gave its accreditation, which exceeds or meets requirements under the clinical laboratory improvement amendments (CLIA) standards, to the Canadian company in 2007.

The accreditation covers standards for quality in day-to-day operations, requires accuracy in performance and proficiency, and includes an on-site lab survey. Its Medical Laboratories division provides specialized testing and lab services for the healthcare and pharmaceutical industries.

Warnex has facilities in Laval and Blainville in Quebec and at Thunder Bay in Ontario.

COLA is a non-profit, physician-directed organization that has been approved by the US government and is sponsored by the American Academy of Family Physicians, the American Medical Association, and other organizations, said Warnex.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.